What is the proper protocol for writing an order for a nicotine replacement inhaler (NRT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Write an Order for Nicotine Replacement Inhaler

Order the nicotine inhaler with an initial dosage of 6-16 cartridges per day for up to 12 weeks, followed by gradual dose reduction over 6-12 weeks, with patients instructed to stop smoking completely on the start date. 1

Essential Order Components

Basic Prescription Format

  • Medication: Nicotine Inhaler (NICOTROL Inhaler) 1
  • Initial dose: 6-16 cartridges per day 1
  • Duration: Up to 12 weeks initial treatment 1
  • Quantity: Dispense sufficient cartridges for initial treatment period (typically 180-480 cartridges for first month) 1
  • Refills: As needed for 12-week initial treatment period 1

Critical Patient Instructions to Include

Smoking cessation requirement: Patient must stop smoking completely when beginning inhaler use 1. This is non-negotiable for treatment success.

Dosing strategy:

  • Most successful patients use 6-16 cartridges daily 1
  • Encourage at least 6 cartridges per day for first 3-6 weeks 1
  • Each cartridge should be puffed continuously for 20 minutes for best effect 1
  • Maximum 16 cartridges per day 1

Patient Selection Criteria

Who Should Receive This Treatment

  • All smokers motivated to quit, regardless of setting 2
  • Particularly effective for those smoking ≥15 cigarettes per day, though lighter smokers can benefit 2
  • The inhaler permits more control over dose and delivery speed compared to patches 2
  • Consider for patients who value the hand-to-mouth ritual of smoking 1

Contraindications to Document

Absolute contraindications:

  • Pregnancy (current UK/guideline position) 2
  • Age <18 years (though this varies by product labeling) 2

Relative contraindications requiring risk assessment:

  • Cardiovascular disease including recent myocardial infarction 2
  • However, NRT is safer than continued smoking even in these patients 2
  • Document risk-benefit discussion when prescribing to these populations 2

Treatment Protocol

Initial Phase (Weeks 1-12)

  • Start with 6-16 cartridges daily 1
  • Average successful quit rate uses >6 cartridges daily 1
  • Regular use during first week helps patients adapt to irritant effects 1
  • Reassess at week 4: If patient has not stopped smoking, discontinue treatment and counsel for future attempt 1

Tapering Phase (Weeks 13-24)

  • Begin gradual reduction after 12 weeks 1
  • Tapering period: 6-12 weeks 1
  • Strategies include: using product less frequently, keeping daily tally, setting reduction targets, or planning a quit date for inhaler discontinuation 1
  • Do not continue beyond 6 months total: Safety and efficacy not established beyond this period 1

Expected Efficacy

The nicotine inhaler approximately doubles cessation rates compared to placebo 3, with an odds ratio of 2.14 (95% CI: 1.44-3.18) 3. This effectiveness is largely independent of the intensity of additional support provided 3.

Combination Therapy Consideration

Combination with nicotine patch may be superior: One high-quality trial showed 60.5% abstinence at 6 weeks with inhaler plus 15mg patch versus 47.5% with inhaler alone (p=0.009), and 19.5% versus 14.0% at 12 months (p=0.14) 4. Consider ordering both products for highly dependent smokers 4.

Common Pitfalls to Avoid

Insufficient dosing: Patients often underdose themselves 1. Emphasize using at least 6 cartridges daily, not just "as needed" 1.

Premature discontinuation: Patients must complete the full 12-week initial treatment 1. Stopping earlier reduces success rates 1.

Incorrect puffing technique: Nicotine is absorbed through oral mucosa, not lungs 5. Instruct patients to puff continuously for 20 minutes per cartridge 1.

Concurrent smoking: Treatment fails if patients continue smoking 1. Set a firm quit date that coincides with starting the inhaler 1.

Side Effects to Counsel

  • Most common: Throat irritation (expected and usually transient) 1, 6
  • Other effects: Nausea, sweating, mood changes, sleep disturbances 7
  • Reassurance: Most adverse effects are mild, transient, and dose-dependent 7, 6
  • Symptoms resolve within 12 hours if exposure discontinued 7

Documentation Requirements

Include in order or chart:

  • Smoking history (cigarettes per day) 2
  • Quit date 1
  • Cardiovascular risk assessment if applicable 2
  • Plan for behavioral support (though not essential for NRT success, it improves outcomes) 3
  • Follow-up schedule at weeks 4,12, and 24 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nicotine replacement therapy for smoking cessation.

The Cochrane database of systematic reviews, 2004

Research

The nicotine inhaler in smoking cessation.

Archives of internal medicine, 1997

Guideline

Nicotine Patch Adverse Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.